E-course: Clinical updates in MIBC setting
Stay at the forefront of muscle-invasive bladder cancer (MIBC) with this e-course. Join leading clinicians and innovators as they discuss the latest data from ESMO 2025 and explore how these findings could shape the future of patient care and clinical practice.
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | 1.00 |
| Duration | Approx. 70 minutes |
Interact and hear directly from the experts participating in the pivotal clinical trials such as KEYNOTE 905, SunRISe-4, and Bladder Path.
Seize this opportunity to enhance your clinical practice by expanding your knowledge and engaging with the experts.
- Prof. J. Aning (GB)
- Dr. B. Pradère (FR)
- Prof. N. James (GB)
- Prof. Dr. J. Bedke (DE)
This e-course is brought to you in collaboration with the EAU Section of Oncological Urology.
Acknowledgment
This activity is supported by an educational grant from our industry partner, with no involvement in the programme or speaker selection.